Credo Technology Group Holding Ltd. (CRDO) just posted the kind of quarter that makes Wall Street recalibrate. The semiconductor company reported second-quarter results Monday that didn't just beat expectations—they demolished them, sending analysts scrambling to revise their models upward.
Here's what happened: Credo delivered adjusted earnings of 67 cents per share, crushing the analyst consensus of 49 cents by a hefty 36%. Revenue came in at $268.03 million, handily beating the $234.92 million estimate. Those aren't incremental beats—those are the kind of numbers that suggest something fundamental is working.
CEO Bill Brennan explained the driver behind the surge: "In the second quarter, Credo delivered revenue of $268 million, an increase of 20% sequentially and an extraordinary 272% increase year-over-year. These are the strongest quarterly results in Credo's history, and they reflect the continued build-out of the world's largest AI training and inference clusters."
The AI infrastructure boom isn't slowing down, and Credo is positioned right in the middle of it. The company's forward guidance underscored that momentum, with third-quarter revenue expected between $335 million and $345 million. That's significantly above the $247.04 million analysts had penciled in.
Investors liked what they heard. Credo shares jumped 13.8% to $194.80 on Tuesday, as the market digested both the results and the optimistic outlook.
The earnings beat triggered a wave of analyst updates, with five major firms raising their price targets:
- Needham analyst N. Quinn Bolton maintained a Buy rating and lifted his target from $190 to $220.
- Barclays analyst Thomas O'Malley kept an Overweight rating and raised his target from $165 to $220.
- B of A Securities analyst Vivek Arya maintained a Buy rating and boosted the target from $165 to $240.
- Mizuho analyst Vijay Rakesh held his Outperform rating while raising the target from $165 to $225.
- Roth Capital analyst Suji Desilva maintained a Buy rating and increased the target from $170 to $250.
The pattern is clear: every analyst who weighed in not only maintained their bullish stance but significantly raised their expectations. When you're growing revenue 272% year-over-year and guiding 40% above consensus for the next quarter, that tends to happen. The AI buildout story has legs, and Credo appears to be running alongside it quite nicely.
